SERPINB5 and neoplasm: Clinical data, however, brought controversies to the field: whereas some studies found a correlation between loss of SerpinB5 and tumor progression in different cancer types including breast [1–3], prostate [4], lung [5, 6] and skin [7], others observed an opposite trend [8–12].